Security

EdenHelp is expected to provide HCPs and patients with real-time access to Rx drug and medical device information.

JAMA Health Forum details the DSCSA and stresses the value of protecting the pharmaceutical supply chain from adulterated products.

This year’s PC Podcast episodes ranged in topic, from DSCSA compliance to pharmacovigilance.

Cloud-based service to address verification of saleable returns under the latest DSCSA regulations.

The seminar examines where members of the pharma supply chain stand in terms of preparation, being that the act has officially been enacted.

Back in Boston, Pharma Commerce tackles all things logistics at LogiPharma USA.

With new mandates right around the corner, there is an unwavering demand for pharma operations to perform at peak efficiency.

Value is attributed to the rise in counterfeit cases and ongoing regulations surrounding anti-counterfeit packaging.

A breakdown on the decision, and how to navigate these obstacles using a network approach.

Conference hosts roundtable chats, with topics ranging from data-driven decision making to cold chain logistics.

LogiPharma session reminds attendees of what to review, as far as DSCSA compliance is concerned.

Pharma Commerce converges on Nation's Capital for HDA Traceability Seminar.

Questions and considerations for pharmaceutical companies in designing and executing strategies to curb the incidence of fake drugs.

Stakeholders uncover the obstacles surrounding the industry onboarding process.

Attendees meet to discuss operational issues related to traceability implementation.

Session offers information on industry readiness, plus an overview of a phase implementation recommendation.

Event’s first session aims to analyze the legislation’s implementation, as FDA enforcement is delayed until November 2024.

Software allows pharmacies to meet legislation’s upcoming Nov. 27 deadline.

The legislation’s deadline for compliance is knocking on the door. Pharma Commerce offers a synopsis of how the Drug Supply Chain Security Act has progressed over the past decade.

DSCSA compliance was also top of mind at the event.

The series’ marking heads help deliver codes to support both product traceability and anti-counterfeiting efforts.

Latest Q4 2022 results show some progress, but 100% readiness by November looks doubtful.

As a November deadline looms for industry compliance with an interoperable system for product tracing, there is more urgency in the US pharma supply chain.

Industry is still scrambling to handle clerical errors of DSCSA transactions.

Event—taking place in Indianapolis—places supply chain education at the forefront.

The Pulse online service will provide free resources to enable pharmacy to meet drug traceability rules.

With the help of traceability, new feature prioritizes efficiency and safety, from production to patient.

Meanwhile, PDG issues more DSCSA guidance on data interoperability.

Citing FDA’s slow guidance, the American Pharmacists Association is requesting delay in November 2023 DSCSA enforcement.

If there’s anything we learned from the pandemic, it’s the critical need to analyze patient outcome data in real time to stay informed on the safety and efficacy of treatments in the real world